BCM
EIDX

BlueCrest Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

BlueCrest Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,294
Closed -$113K – 1602
2018
Q3 		$113K Buy
11,294
+44
+0.4% +$440 ﹤0.01% 1359
2018
Q2 		$229K Buy
+11,250
New +$229K 0.01% 1214